Therapeutic Inhibition of USP7-PTEN Network in Chronic Lymphocytic Leukemia: A Strategy to Overcome TP53 Mutated/Deleted Clones

Oncotarget - United States
doi 10.18632/oncotarget.16348
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Unravelling the Suboptimal Response of TP53 -Mutated Chronic Lymphocytic Leukaemia to Ibrutinib

British Journal of Haematology
Hematology
2018English

Novel CHK1 Inhibitor MU380 Exhibits Significant Single-Agent Activity in TP53-mutated Chronic Lymphocytic Leukemia Cells

Haematologica
Hematology
2019English

Refractory Chronic Lymphocytic Leukemia – New Therapeutic Strategies

Oncotarget
Oncology
2010English

TP53 Gene Mutation Analysis in Chronic Lymphocytic Leukemia by Nanopore MinION Sequencing

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2016English

HIF-1α Is Overexpressed in Leukemic Cells From TP53-disrupted Patients and Is a Promising Therapeutic Target in Chronic Lymphocytic Leukemia

Haematologica
Hematology
2019English

Prognosis and New Therapeutic Approaches in Chronic Lymphocytic Leukemia Treatment

Medicinski podmladak
2019English

Lymphocyte Activation Gene 3: A Novel Therapeutic Target in Chronic Lymphocytic Leukemia

Haematologica
Hematology
2017English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy